{
    "clinical_study": {
        "@rank": "97671", 
        "brief_summary": {
            "textblock": "RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing\n      so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor\n      cells. Combining more than one chemotherapy drug with radiation therapy may kill more tumor\n      cells. It is not yet known which treatment regimen is more effective for small cell lung\n      cancer.\n\n      PURPOSE: Randomized phase III trial to study the effectiveness of combination chemotherapy\n      using two different doses of cyclophosphamide followed by alternating chemotherapy and\n      radiation therapy in treating patients with small cell lung cancer."
        }, 
        "brief_title": "Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Small Cell Lung Cancer", 
        "condition": "Lung Cancer", 
        "condition_browse": {
            "mesh_term": [
                "Lung Neoplasms", 
                "Small Cell Lung Carcinoma"
            ]
        }, 
        "detailed_description": {
            "textblock": "OBJECTIVES: I. Compare the effect on 2-year disease-free survival of two different doses of\n      cyclophosphamide as part of first induction chemotherapy followed by alternating\n      chemotherapy and chest irradiation in patients with limited stage small cell lung cancer.\n\n      OUTLINE: This is a randomized study. Patients are stratified by participating institution.\n      All patients receive 2 courses of induction chemotherapy with doxorubicin, etoposide,\n      cisplatin, and cyclophosphamide. For the first course, one group of patients receives a\n      lower dose of cyclophosphamide than the other group. Both groups receive the same, and still\n      lower, dose of cyclophosphamide during the second course. Beginning 1 week after the\n      completion of induction therapy, patients receive 3 alternating courses each of radiotherapy\n      to the mediastinal and supraclavicular areas delivered over 10-12 days and chemotherapy as\n      in the second course of induction. Each course is initiated after a 1-week rest. Patients\n      receive a final chemotherapy course beginning 4 weeks after the previous chemotherapy\n      course. Patients are followed every 6 months for survival.\n\n      PROJECTED ACCRUAL: A total of 280 patients will be entered."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "DISEASE CHARACTERISTICS: Histologically proven small cell lung cancer with no distant\n        metastases Size of initial lesion suitable for total irradiation Positive subclavicular\n        nodes allowed No malignant pleural effusion No extension into contralateral lung\n\n        PATIENT CHARACTERISTICS: Age: Under 70 Performance status: Karnofsky 60%-100%\n        Hematopoietic: WBC greater than 2,000 Platelets greater than 125,000 Hepatic: Not\n        specified Renal: Creatinine less than 1.1 mg/dL (100 micromoles/L) Cardiovascular: No\n        myocardial infarction within 6 months No other cardiovascular disease that precludes\n        protocol treatment Other: No hearing loss No prior or concurrent malignancy except: Basal\n        cell skin carcinoma In situ carcinoma of the cervix Accessible for follow-up\n\n        PRIOR CONCURRENT THERAPY: No prior chemotherapy, radiotherapy, or surgery"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "69 Years", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "280", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 1, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00002858", 
            "org_study_id": "CDR0000065122", 
            "secondary_id": [
                "FRE-CPC014", 
                "EU-96009"
            ]
        }, 
        "intervention": [
            {
                "intervention_name": "cisplatin", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "cyclophosphamide", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "doxorubicin hydrochloride", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "etoposide", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "radiation therapy", 
                "intervention_type": "Radiation"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Cisplatin", 
                "Cyclophosphamide", 
                "Doxorubicin", 
                "Etoposide"
            ]
        }, 
        "keyword": "limited stage small cell lung cancer", 
        "lastchanged_date": "February 6, 2009", 
        "link": {
            "description": "Clinical trial summary from the National Cancer Institute's PDQ\u00ae database", 
            "url": "http://cancer.gov/clinicaltrials/FRE-CPC014"
        }, 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Angers", 
                        "country": "France", 
                        "zip": "49036"
                    }, 
                    "name": "Centre Paul Papin"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Angers", 
                        "country": "France", 
                        "zip": "49033"
                    }, 
                    "name": "Centre Hospitalier Regional et Universitaire d'Angers"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bordeaux", 
                        "country": "France", 
                        "zip": "33076"
                    }, 
                    "name": "Institut Bergonie"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Caen", 
                        "country": "France", 
                        "zip": "14076"
                    }, 
                    "name": "Centre Regional Francois Baclesse"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Clamart", 
                        "country": "France", 
                        "zip": "92141"
                    }, 
                    "name": "Hopital Antoine Beclere"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Corbeil", 
                        "country": "France", 
                        "zip": "91100"
                    }, 
                    "name": "Centre Hospitalier Sud Francilien - Site Corbeil"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Creteil", 
                        "country": "France", 
                        "zip": "94010"
                    }, 
                    "name": "Hopital Intercommunal De Creteil"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dijon", 
                        "country": "France", 
                        "zip": "21079"
                    }, 
                    "name": "Centre de Lute Contre le Cancer,Georges-Francois Leclerc"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dijon", 
                        "country": "France", 
                        "zip": "21034"
                    }, 
                    "name": "Hopital De La Trouhade"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Montbeliard", 
                        "country": "France", 
                        "zip": "25209"
                    }, 
                    "name": "C.H. General Andre Boulloche"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nantes-Saint Herblain", 
                        "country": "France", 
                        "zip": "44805"
                    }, 
                    "name": "CRLCC Nantes - Atlantique"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nice", 
                        "country": "France", 
                        "zip": "06189"
                    }, 
                    "name": "Centre Antoine Lacassagne"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Pessac", 
                        "country": "France", 
                        "zip": "33604"
                    }, 
                    "name": "Hopital Haut Leveque"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Saumur", 
                        "country": "France", 
                        "zip": "49403"
                    }, 
                    "name": "C.H. De Saumur"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Strasbourg", 
                        "country": "France", 
                        "zip": "67091"
                    }, 
                    "name": "Hopitaux Universitaire de Strasbourg"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Toulouse", 
                        "country": "France", 
                        "zip": "31052"
                    }, 
                    "name": "Institut Claudius Regaud"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Vandoeuvre-les-Nancy", 
                        "country": "France", 
                        "zip": "54511"
                    }, 
                    "name": "Centre Alexis Vautrin"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Vandoeuvre-Les-Nancy", 
                        "country": "France", 
                        "zip": "54511"
                    }, 
                    "name": "CHRU de Nancy - Hopitaux de Brabois"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Villejuif", 
                        "country": "France", 
                        "zip": "F-94805"
                    }, 
                    "name": "Institut Gustave Roussy"
                }
            }
        ], 
        "location_countries": {
            "country": "France"
        }, 
        "official_title": "PHASE III STUDY COMPARING TWO DOSES OF INDUCTION CHEMOTHERAPY FOLLOWED BY ALTERNATION OF CHEMOTHERAPY AND RADIOTHERAPY IN LIMITED SMALL CELL LUNG CANCER", 
        "overall_official": {
            "affiliation": "Gustave Roussy, Cancer Campus, Grand Paris", 
            "last_name": "Thierry L. Le Chevalier, MD", 
            "role": "Study Chair"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "Phase 3", 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00002858"
        }, 
        "source": "National Cancer Institute (NCI)", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Gustave Roussy, Cancer Campus, Grand Paris", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 1993", 
        "study_design": "Allocation: Randomized, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2007"
    }, 
    "geocoordinates": {
        "C.H. De Saumur": "47.26 -0.081", 
        "C.H. General Andre Boulloche": "47.51 6.798", 
        "CHRU de Nancy - Hopitaux de Brabois": "48.661 6.174", 
        "CRLCC Nantes - Atlantique": "47.21 -1.602", 
        "Centre Alexis Vautrin": "48.661 6.174", 
        "Centre Antoine Lacassagne": "43.696 7.266", 
        "Centre Hospitalier Regional et Universitaire d'Angers": "47.478 -0.563", 
        "Centre Hospitalier Sud Francilien - Site Corbeil": "48.578 4.425", 
        "Centre Paul Papin": "47.478 -0.563", 
        "Centre Regional Francois Baclesse": "49.183 -0.371", 
        "Centre de Lute Contre le Cancer,Georges-Francois Leclerc": "47.322 5.041", 
        "Hopital Antoine Beclere": "48.8 2.257", 
        "Hopital De La Trouhade": "47.322 5.041", 
        "Hopital Haut Leveque": "44.806 -0.63", 
        "Hopital Intercommunal De Creteil": "48.79 2.456", 
        "Hopitaux Universitaire de Strasbourg": "48.583 7.748", 
        "Institut Bergonie": "44.838 -0.579", 
        "Institut Claudius Regaud": "43.605 1.444", 
        "Institut Gustave Roussy": "48.793 2.359"
    }
}